Default company panoramic image
24f08d52 da31 4c1b 8c03 29ae7763574c

EndoRetics, Inc.

EndoRetics is commercializing an endolumenal incisionless reversible bariatric device for the treatment of obesity.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Columbus, OH, USA
  • Currency USD

Company Summary

Obesity is a growing global epidemic without sufficient treatments. The EndoRetics device will provide surgeons and gastroenterologists with the ability to create a small gastric pouch in the upper stomach without the need for a surgery suite and no general anesthetic. The low cost, reversible, incisionless procedure will be performed on an outpatient basis. Easy transferability will allow more physicians to treat patients for obesity.

Team

  • Default avatar
    Vincent Kazmer
    CEO, Founder

    Mr. Kazmer has over 25 years of experience in all phases of life science technology business formation and management. He has served as CEO of five biotech companies; both public and venture capital financed, and founded three university spinout life science companies.

  • Default avatar
    Bradley Needleman
    Board Member, Founder

    Dr. Needleman is Associate Professor of Clinical Surgery and Director, Bariatric Surgery Program, Center for Minimally Invasive Surgery, Department of Surgery, The Ohio State University. His research and specialty interests include advanced laparoscopic surgery, obesity, metabolic surgery, minimally invasive surgery, bariatric surgery and surgical education. Dr. Needleman has performed more than 2000 bariatric procedures and trained more than 100

  • Default avatar
    Jeffrey Hazey
    Board Member, Founder

    Dr. Hazey is Associate Professor of Surgery, Center for Minimally Invasive Surgery, Department of Surgery, The Ohio State University. He specializes in minimally invasive surgery, advanced endoscopy and natural orifice transluminal endoscopic surgery (NOTES). Dr. Hazey has conducted numerous clinical trials and consults in the area of minimally invasive surgery and NOTES.

  • Default avatar
    Matt Huddleston
    Vice President, Engineering

    Mr. Huddleston has over 12 years of experience in medical device development including project management, design and development, verification and validation testing, regulatory affairs and intellectual property. He is a USPTO Patent Agent, Professional Engineer and the Principal Investigator for the EndoRetics SBIR grant application titled, “Incisionless Endoluminal Bariatric Device Design and Testing.”

Previous Investors

  • Default avatar
    TechColumbus, Columbus, Ohio
    Unconfirmed